Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) has shared an update.
Lee’s Pharmaceutical Holdings Limited announced an interim cash dividend of HKD 0.022 per share for the six months ending 30 June 2025. The ex-dividend date is set for 12 September 2025, with the payment date scheduled for 03 October 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders, potentially enhancing its attractiveness to investors.
The most recent analyst rating on (HK:0950) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Lee’s Pharmaceutical Holdings Limited stock, see the HK:0950 Stock Forecast page.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is known for its commitment to providing innovative and high-quality healthcare solutions.
Average Trading Volume: 2,665,358
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.19B
Learn more about 0950 stock on TipRanks’ Stock Analysis page.